GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Exam Corner/Leptin Vs Ghrelin

Leptin Vs Ghrelin

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated September 1, 2025

Quick Answer

Ghrelin and leptin are two pivotal hormones that regulate appetite, energy balance, and metabolism. They work in opposing ways, yet their interplay is crucial for maintaining the body’s homeostasis.


Ghrelin and leptin are two pivotal hormones that regulate appetite, energy balance, and metabolism. They work in opposing ways, yet their interplay is crucial for maintaining the body’s homeostasis. Below is a comprehensive comparison of **leptin** and **ghrelin**, focusing on their sources, roles, mechanisms, and clinical significance.

---

### **1. Overview**

| **Feature** | **Ghrelin** | **Leptin** |

|---------------------------|-------------------------------------------------|------------------------------------------------|

| **Primary Role** | Stimulates hunger (orexigenic hormone) | Suppresses hunger (anorexigenic hormone) |

| **Nicknames** | "Hunger Hormone" | "Satiety Hormone" |

---

### **2. Source and Secretion**

#### **Ghrelin**:

  • **Primary Source**: Secreted by enteroendocrine cells (P/D1 cells) in the **fundus of the stomach**.
  • **Secondary Sources**: Duodenum, ileum, colon, pancreas, and hypothalamus.
  • **Secretion Trigger**: Levels rise during **fasting** and peak before meals, signaling hunger.

#### **Leptin**:

  • **Primary Source**: Produced by **adipocytes** (fat cells) in proportion to fat stores.
  • **Secondary Sources**: Placenta, skeletal muscle, and gastric mucosa.
  • **Secretion Trigger**: Levels increase with **fat accumulation** and decrease during caloric restriction or weight loss.

---

### **3. Mechanism of Action**

#### **Ghrelin**:

1. **Central Action**:

  • Acts on the **arcuate nucleus** of the hypothalamus.
  • Stimulates **neuropeptide Y (NPY)** and **agouti-related peptide (AgRP)** neurons, which promote hunger.

2. **Peripheral Effects**:

  • Activates **growth hormone secretagogue receptor (GHSR)** to stimulate growth hormone secretion.
  • Enhances gastrointestinal motility and gastric emptying.

#### **Leptin**:

1. **Central Action**:

  • Acts on the **ventromedial nucleus** of the hypothalamus.
  • Suppresses NPY/AgRP neurons and activates **pro-opiomelanocortin (POMC)** neurons, which produce **melanocyte-stimulating hormone (MSH)** to reduce appetite.

2. **Peripheral Effects**:

  • Increases energy expenditure by enhancing thermogenesis.
  • Regulates glucose and lipid metabolism.

---

### **4. Functions**

| **Function** | **Ghrelin** | **Leptin** |

|----------------------------|-------------------------------------------------|------------------------------------------------|

| **Appetite Regulation** | Stimulates hunger and food intake | Inhibits hunger and promotes satiety |

| **Energy Balance** | Promotes energy storage (anabolism) | Promotes energy expenditure (catabolism) |

| **Growth Hormone** | Stimulates growth hormone release | No direct effect |

| **Metabolic Effects** | Enhances gastric motility and fat deposition | Regulates glucose and lipid metabolism |

| **Circadian Rhythm** | Peaks before meals, signaling meal initiation | Maintains long-term energy balance |

---

### **5. Levels in Clinical Conditions**

#### **Ghrelin**:

  • **High Levels**:
  • **Fasting**: Signals hunger and meal initiation.
  • **Cachexia and anorexia nervosa**: Compensatory rise due to negative energy balance.
  • **Weight loss**: Levels increase after caloric restriction.
  • **Low Levels**:
  • **Obesity**: Suppressed ghrelin levels, possibly due to chronic overeating.
  • **Post-gastric bypass surgery**: Significant reduction in ghrelin levels contributes to weight loss.

#### **Leptin**:

  • **High Levels**:
  • **Obesity**: Paradoxically elevated due to increased fat stores, but associated with **leptin resistance**.
  • **Inflammatory states**: Leptin acts as a pro-inflammatory cytokine.
  • **Low Levels**:
  • **Fasting or caloric restriction**: Levels drop rapidly, stimulating hunger.
  • **Lipodystrophy**: Reduced fat stores lead to leptin deficiency.

---

### **6. Clinical Significance**

#### **Ghrelin**:

1. **Role in Obesity**:

  • Despite low ghrelin levels in obesity, reduced sensitivity to ghrelin may contribute to dysregulated appetite.
  • Therapeutic approaches targeting ghrelin include **ghrelin receptor antagonists**.

2. **Post-Bariatric Surgery**:

  • Reduction in ghrelin levels contributes to decreased appetite and sustained weight loss.

3. **Cachexia**:

  • Elevated ghrelin levels reflect the body's attempt to increase food intake during negative energy balance.

#### **Leptin**:

1. **Leptin Resistance**:

  • Common in obesity; despite high leptin levels, the hypothalamus fails to respond, leading to persistent hunger.
  • Research focuses on overcoming leptin resistance to treat obesity.

2. **Leptin Deficiency**:

  • Rare genetic condition causing severe obesity and hyperphagia from infancy.
  • Treated with recombinant leptin therapy.

3. **Inflammation**:

  • Leptin’s role as a cytokine links it to autoimmune diseases and metabolic syndrome.

---

### **7. Comparison Table**

| **Feature** | **Ghrelin** | **Leptin** |

|----------------------------|-------------------------------------------------|------------------------------------------------|

| **Source** | Stomach (fundus) | Adipocytes (fat cells) |

| **Role** | Stimulates hunger | Suppresses hunger |

| **Effect on Appetite** | Increases food intake | Decreases food intake |

| **Energy Balance** | Promotes energy storage | Promotes energy expenditure |

| **Clinical Association** | Elevated in fasting, cachexia | Elevated in obesity, leptin resistance |

---

### **8. Interplay Between Ghrelin and Leptin**

  • **Opposing Functions**:
  • Ghrelin promotes hunger when energy reserves are low, while leptin suppresses hunger when energy reserves are sufficient.
  • **Circadian Regulation**:
  • Ghrelin levels peak before meals, signaling meal initiation, while leptin maintains long-term energy balance.
  • **Clinical Implications**:
  • Disruption in the balance between ghrelin and leptin contributes to obesity, anorexia, and metabolic disorders.

---

### **9. Clinical Pearls**

  • **Ghrelin**: Think of it as the "hunger hormone" that drives meal initiation during fasting or starvation.
  • **Leptin**: Think of it as the "satiety hormone" that signals fullness and regulates long-term energy balance.
  • **Obesity**: Often associated with **high leptin (resistance)** and **low ghrelin** levels, creating a dysregulated appetite control mechanism.

---

### **Summary**

  • **Ghrelin** stimulates hunger and promotes energy storage, while **leptin** suppresses hunger and enhances energy expenditure.
  • Both hormones act on the hypothalamus but have opposite effects on appetite regulation.
  • Their dysregulation is implicated in conditions like obesity, anorexia nervosa, cachexia, and metabolic syndrome.
  • Therapeutic interventions targeting ghrelin and leptin pathways are being explored for obesity and eating disorders.

Related Q&A

Dopamine Beyond Reward. JAMA| May 2026

This review redefines dopamine (DA) signaling beyond its classical role in reward processing, positioning dopaminergic circuits as central regulators of feeding behavior, metabolic sensing, and energy homeostasis. The authors describe how distributed dopamine ensembles across...

Gut–Heart Axis: Gut | May 2026

Introduction Atherosclerosis has traditionally been viewed as a lipid-driven disease. However, emerging evidence highlights a critical role of chronic inflammation and immune activation, with the gut microbiota now recognised as a key modulator of vascular...

Bleeding Risk with Apixaban vs. Rivaroxaban: NEJM March 2026

Clinical Summary In this randomized international trial (COBRRA), investigators compared the bleeding risk of apixaban vs. rivaroxaban in patients with acute venous thromboembolism (VTE), including pulmonary embolism and proximal deep-vein thrombosis. A total of 2,760...

ACG 2025

The American College of Gastroenterology (ACG) 2025 meeting is a prominent annual event where groundbreaking research, clinical studies, and advancements in gastroenterology are presented. At the ACG 2025 meeting, several impactful studies were showcased, providing...

Alcohol Use Disorder (AUD) with Alcohol-Related Liver Disease (ArLD) - Pharmacology

Alcohol Use Disorder (AUD) and Alcohol-Related Liver Disease (ArLD) often coexist, presenting a complex clinical challenge that requires careful consideration of pharmacological treatment. Below is a detailed explanation starting from definitions, the need for pharmacological...

The role of copper dysregulation in Wilson disease

Copper dysregulation plays a central role in the pathogenesis of Wilson disease (WD). The disease arises from the body’s inability to regulate copper levels, leading to its accumulation and subsequent toxicity. Below is a detailed...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer